The Alere Reader provides objective result interpretation and is a simple, straightforward testing procedure. It is to be used with either nasopharyngeal swab or nasal swab samples.
Features
- Alere BinaxNOW® Influenza A & B Card 2 must be read by the Alere™ Reader
- The first rapid antigen influenza test to achieve 510(k) clearance as a Class II assay under the new FDA Reclassification performance requirements
- Alere™ Reader provides objective result interpretation
- Used with either nasopharyngeal swab or nasal swab samples
- Simple, straightforward testing procedure
